Time
|
Subject
|
Speaker
|
|
9:00-9:30
|
Registration
|
||
9:30-9:40
10 mins
|
《Welcome Remarks & Group Photo》
Guests of Honor:Jang-Hwa Leu, Director General, MOEAIDB /
Herbert Wu, Director, BPIPO
Moderator:Wei-Kuang Chi, Executive Director, DCB
|
||
9:40-10:20
40 mins
|
How a biomedical cluster will be formed in Taiwan?
-Share the experience in Kobe-
如何構築臺灣生醫聚落
-神戶經驗分享-
|
Shin KAWAMATA MD. PhD.
川真田 伸
Director,
Research and Development Center for Cell Therapy, Foundation for Biomedical Research and Innovation at Kobe
細胞療法研發中心 中心長
|
|
10:20-10:40
20 mins
|
Challenge to Cell Therapy
Astellas藥廠於細胞治療之挑戰
|
Hiroko IDE PhD.
井出 寛子
Research Fellow,
Institute for Regenerative Medicine Satellite Office, Drug Discovery Research, Astellas Pharma Inc.
Astellas藥廠 研究員
|
|
10:40-10:50
10 mins
|
Break time
|
||
10:50-11:10
20 mins
|
Development of Allogeneic Cell Therapy Products: The end of Cajal’s dogma
異體細胞治療產品之開發:終結Cajal教條
|
Takehiko KANEKO MD.
金子 健彥
Medical Director & Head of Development Japan,SanBio Company Limited
SanBio公司 醫學部門主管及日本開發部門主席
|
|
11:10-11:30
20 mins
|
Experiences of Cell Manufacturing for Medical Care in Japan
細胞製造於日本新興醫療之應用經驗
|
Kunihiko SUZUKI
鈴木 邦彥
Vice President & Member of the Board, MEDINET Co., Ltd.
MEDINET 副總裁/董事
|
|
11:30-11:50
20 mins
|
|
||
11:50-12:30
40 mins
|
Open Networking
|
MEDGAEA LIFE SCIENCES LTD.
Copyright©2012 Medgaea Life Sciences Ltd.All Rights Reserved.
Address:7F., No.45, Lane 3, Sec.1, Zhongzheng E.Rd., Tamsui, New Taipei City 25147, Taiwan
Telephone:+886-2-2625-3300 Email:service@medgaea.com.tw